Cathie Wood’s ARK Innovation ETF Sinks During Selloff

A broad sell-off in tech stocks is penalizing fund manager Cathie Wood’s flagship ARK Innovation exchange-traded fund. The popular ETF, which goes by the ticker ARKK and focuses on high-growth, “disruptive” companies, fell 5.5% on Friday, while technology stocks fell sharply. Concerns about inflation and the potential economic impact of the novel Omicron variant of … Read more

Elizabeth Holmes’ long-shot defense may be all she’s got, experts say:

Font size Theranos founder and former CEO Elizabeth Holmes. Getty Images In testimony at her trial this week, ex-Theranos CEO Elizabeth Holmes said she was the unwitting figurehead of a company controlled by an allegedly abusive ex-boyfriend. It boils down to a brief defense that may be her best hope against allegations she deliberately misled … Read more

Omicron Variant Notifies Businesses During the Holiday Season

Concerns over a new Covid-19 variant are prompting some US companies to double down on vaccine mandates and rethink organizing holiday festivities this month, while many others are taking a wait and see approach as they look to government agencies for more guidance. Since the discovery of the Omicron coronavirus variant was announced last week, … Read more

Lilly’s Covid-19 Antibody Treatment Approved for Use in Children

The monoclonal antibody drug from Eli Lilly & Co. is approved for emergency use in children under 12, the Food and Drug Administration said Friday. The approval is the first for an antibody drug to treat young children, including newborns, who have tested positive for Covid-19 or have been exposed to the virus and who … Read more

Lilly’s Covid-19 Antibody Treatment Approved for Use in Children

The monoclonal antibody drug from Eli Lilly & Co. is approved for emergency use in children under 12, the Food and Drug Administration said Friday. The approval is the first for an antibody drug to treat young children, including newborns, who have tested positive for Covid-19 or have been exposed to the virus and who … Read more

The huge promise of mRNA technology

Are Covid-19 Vaccines a Failure? That is the view in some media circles amid breakthrough infections and new virus variants. It’s also false. Vaccinated people are more susceptible to mild infections than public health authorities initially expected. But the injections continue to provide strong protection against serious diseases, and in particular the mRNA vaccines – … Read more

Former Unilever CIO moves into healthcare

Jane Moran, former Global Chief Information Officer at Unilever PLC, is working to improve technology in a Boston-based healthcare system, including improving the hospital experience for patients and their families. Ms. Moran joined Mass General Brigham Inc. in September. as Chief Information and Digital Officer, a newly created position that oversaw some 2,000 people. Mass … Read more

Covid-19 Vaccine Question Strains CVS, Walgreens

The US has many Covid-19 vaccines, but retail pharmacies are struggling to deliver them quickly in some places. Vaccine seekers in some states face wait times of days or weeks for doses as local health officials work to improve access to meet rising demand. CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc., which … Read more

Cathie Wood’s ARK Innovation ETF Sinks During Selloff

A broad sell-off in tech stocks is penalizing fund manager Cathie Wood’s flagship ARK Innovation exchange-traded fund. The popular ETF, which goes by the ticker ARKK and focuses on high-growth, “disruptive” companies, fell 5.5% on Friday, while technology stocks fell sharply. Concerns about inflation and the potential economic impact of the novel Omicron variant of … Read more

Merck in supply deal with Canada for antiviral drugs for Covid-19

By Michael Dabaie Merck & Co. Inc. said it has a supply agreement with the Canadian government for up to 1 million patient courses of molnupiravir, the investigational oral antiviral drug for the treatment of Covid-19. Merck is developing molnupiravir in collaboration with Ridgeback Biotherapeutics. The government of Canada will have access to 500,000 patient … Read more